Business Systems Analyst

Your mission

As a Business Systems Analyst, you will play a key role in enabling MeiraGTx to optimise its core business platforms: NetSuite, MasterControl, and Veeva. Acting as a bridge between business functions and IT, you will work closely with stakeholders across Finance, Quality, Clinical, Operations, and Supply Chain to gather requirements, design solutions, and ensure systems evolve in line with business and regulatory needs. This role provides the opportunity to shape how key systems support business processes in a dynamic, fast-growing, and highly regulated environment. Job Description

Job Responsibilities

• Partner with business stakeholders to understand processes, pain points, and requirements across Finance, Quality, Clinical, and Operations.
• Translate business requirements into functional specifications and system enhancements.
• Support the evaluation and implementation of new features, workflows, and modules within NetSuite, MasterControl, and Veeva.
• Coordinate and manage Change Control processes within MasterControl, ensuring compliance with Quality and IT governance.
• Facilitate workshops, walkthroughs, and user acceptance testing to validate system changes.
• Provide guidance, training, and documentation to end-users, driving adoption and effective use of systems.
• Develop and maintain reports, dashboards, and data insights to support decision-making.
• Act as liaison between users and external vendors/consultants when required.
• Promote continuous improvement by identifying opportunities to streamline business processes through system functionality.
• Support audits and inspections by ensuring system processes meet compliance and documentation standards.
• Perform day-to-day general administration of assigned systems, including user onboarding, access management, routine support activities, and any other tasks or responsibilities as assigned by the line manager or department head.

Job Background

• Proven experience as a Business Systems Analyst or similar role with exposure to ERP, QMS, and/or Clinical systems.
• Strong knowledge of NetSuite (finance, supply chain, or manufacturing modules).
• Familiarity with MasterControl (Quality Management System) and/or Veeva Vault (QMS, RIM, or Clinical).
• Experience working in regulated industries such as biotech, pharma, or medical devices.
• Strong analytical and problem-solving skills with the ability to document and communicate requirements effectively.
• Comfortable facilitating workshops and liaising with stakeholders across multiple business functions.
• Experience with Change Control, validation, and compliance processes in a regulated environment.
• Knowledge of multi-subsidiary and multi-currency environments advantageous.
• Excellent communication skills with a focus on stakeholder engagement and cross-functional collaboration.

Why us?

About us

MeiraGTx is a clinical-stage gene therapy company focused on developing potentially curative treatments for patients living with serious diseases. We currently have six programs in clinical development including three ocular indications, a salivary gland condition, and a Parkinson’s disease program. Our initial focus on diseases of the eye, salivary gland and central nervous system is based on the significant unmet medical need coupled with the high potential gene therapy has to provide meaningful clinical benefit in these areas. With headquarters in New York and London, our global footprint provides us the opportunity to partner with leading institutions around the world, allowing us to deepen our understanding of diseases and their progression.

Our team was built with deep expertise in gene therapy development, allowing us to efficiently advance our programs from preclinical to clinical development. Our core capabilities in viral vector design and optimization and gene therapy manufacturing give us a differentiated approach to developing gene therapies. Additionally, we are developing proprietary technology to potentially enable innovative gene therapy treatments whose expression can be turned on and off with an easily administered small molecule. We believe temporal control of gene therapy products has the potential to transform the gene therapy landscape.

Our state-of-the-art manufacturing facility, completed in early 2018, was designed to meet global regulatory requirements, including the current good manufacturing practices (cGMP) required by the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK and the U.S. Food and Drug Administration (FDA). The 29,000-square foot facility has the flexibility and capacity to produce sufficient product for all our clinical trials and will scale to commercial capacity.